Bone Turnover in Azerbaijani Patients with Type 2 Diabetes

  • Sain Sattar SAFAROVA ORCID Mail Department of Internal Medicine, Azerbaijan Medical University, Baku, Azerbaijan

Abstract

No Abstract

References

1. Jørgensen HS, Winther S, Bøttcher M, et al (2017). Bone turnover markers are asso-ciated with bone density, but not with fracture in end stage kidney disease: a cross-sectional study. BMC Nephrol, 18: 284.
2. Nakashima A, Yokoyama K, Yokoo T, Urashima M (2016). Role of vitamin D in diabetes mellitus and chronic kidney dis-ease. World J Diabetes, 7(5):89–100.
3. Norris R, Parker M (2011). Diabetes mellitus and hip fracture: a study of 5966 cases. Injur, 42 (11):1313-6.
4. Abdulameer SA, Sulaiman SA, Hassali MA, et al (2012).Osteoporosis and type 2 dia-betes mellitus: what do we know, and what we can do? Patient Prefer Adherence, 6:435–448.
5. Fisher A, Srikusalanukul W, Fisher L, Smith PN (2017). Lower serum P1NP/β-CTX ratio and hypoalbuminemia are inde-pendently associated with osteoporotic nonvertebral fractures in older adults. Clin Interv Aging, 12: 1131–1140.
6. Hinton PS (2016). Role of reduced insulin-stimulated bone blood flow in the patho-genesis of metabolic insulin resistance and diabetic bone fragility. Medical Hypoth-eses, 93:81–86.
Published
2020-10-01
How to Cite
1.
SAFAROVA S. Bone Turnover in Azerbaijani Patients with Type 2 Diabetes. Iran J Public Health. 49(10):2014-2015.
Section
Letter to the Editor